Found 15 articles for: "Eczema"
Use of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals
August 2026 | Volume 25 | Issue 8 | Original Article | 737 | Copyright © August 2026
Background: Eczema is a prevalent, chronic skin condition that affects up to 10% of adults globally and is characterized by recurrent eczematous lesions. Intense itch is often th...
Read MoreAtopic Dermatitis Flare Following Initiation of Nemolizumab
August 2026 | Volume 25 | Issue 8 | Case Reports | 751 | Copyright © August 2026
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by intense pruritus and episodic flares. While nemolizumab, an interleukin-31 (IL-31) inhibitor,...
Read MoreExpert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | Original Article | 228 | Copyright © March 2026
Background: Chronic hand eczema (CHE) is a common, heterogeneous inflammatory skin disease associated with substantial symptom burden, impaired hand function, reduced quality of ...
Read MoreRuxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Original Article | 1036 | Copyright © October 2025
Atopic dermatitis (AD), a chronic inflammatory skin disease, is typically treated with topical corticosteroids in patients with mild to moderate disease, creating an ongoing need for nonsteroidal...
Read MoreBeyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
Treating Chronic Hand Eczema with Upadacitinib: Insights from Clinical Trials and Real-World Experience
July 2025 | Volume 24 | Issue 7 | Features | 702 | Copyright © July 2025
Background: Chronic hand eczema (CHE) is a chronic inflammatory skin condition that affects the hands and wristscausing itching, dryness, cracking, and pain. It ofte...
Read MoreSocioeconomic Disparities in Gentle Skin Care Access for Atopic Dermatitis: Affordability and Pharmacy Deserts
July 2025 | Volume 24 | Issue 7 | Original Article | 683 | Copyright © July 2025
Background: Gentle skin care is key to atopic dermatitis (AD) treatment, yet products are often expensive. Pharmacy deserts may exacerbate socioeconomic disparities in AD....
Read MoreAn Unusual Case of Psoriasiform Dermatitis Treated With Dual Biologic Therapy and Literature Review
February 2025 | Volume 24 | Issue 2 | Case Reports | 207 | Copyright © February 2025
Previously believed to be of distinct immunopathogenesis, atopic dermatitis (AD) and psoriasis (PsO) spectrum may permit immunologic shifts to favor the opposing inflammatory states following bio...
Read MoreAssessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema
October 2024 | Volume 23 | Issue 10 | Original Article | 834 | Copyright © October 2024
Read MoreMycosis Fungoides Palmaris et Plantaris Mimicking "Dyshidrotic Eczema": A Case Report
July 2024 | Volume 23 | Issue 7 | Case Reports | 569 | Copyright © July 2024
Mycosis fungoides palmaris et plantaris (MFPP) is a rare variant of mycosis fungoides (MF), a type of cutaneous T-cell lymphoma. MFPP primarily affects the palms and soles of the feet and is ofte...
Read MoreWhy Does Facial Eczema Differ From Body Eczema?
October 2022 | Volume 21 | Issue 10 | Case Reports | 1119 | Copyright © October 2022
Background: The pathophysiology of atopic dermatitis (AD) is multifactorial, influenced by genetics, skin barrier dysfunction, and environmental stressors. There is a lack of research...
Read MoreEvaluation of Cannabis and Cannabinoid Product Use, Knowledge, and Attitudes in the Eczema Community
April 2022 | Volume 21 | Issue 4 | Original Article | 413 | Copyright © April 2022
Background: Data to date supports the potential for targeting the cutaneous endocannabinoid system to treat eczematous dermatoses. However, our understanding of patient knowledge and ...
Read MoreTwo Cases of Recalcitrant Dyshidrotic Eczema Treated With Dupilumab
May 2021 | Volume 20 | Issue 5 | Features | 558 | Copyright © May 2021
Dyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a chronic, relapsing palmoplantar...
Read MoreA Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab
February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019
A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years tha...
Read MoreDupilumab in the Treatment of Dyshidrosis: A Report of Two Cases of Dyshidrotic Eczema
March 2018 | Volume 17 | Issue 3 | Case Reports | 355 | Copyright © March 2018
Dyshidrotic eczema is a distinct entity, often considered on the spectrum of atopic dermatitis, that primarily effec...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
